Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005)

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 2, 2008, Pages 131-134

  Alavian, Seyed Moayed ^a,b   Mansouri, Siavash ^c   Abouzari, Mehdi ^a,d   Assari, Shervin ^b   Bonab, Mirmohsen Sharifi ^b   Miri, Seyed Mohammad ^a  

^a Baqiyatallah Research Center for Gastroenterology and Liver Disease   (Iran)

^b Baqiyatallah Medical Sciences University Baqyatallah Hospital   (Iran)

^c Oil Company Hospital   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Efficacy; Healthcare workers; Hepatitis B virus; Vaccination

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; DRUG EFFICACY; FEMALE; HEALTH CARE PERSONNEL; HEPATITIS B; HUMAN; INFECTION PREVENTION; IRAN; MAJOR CLINICAL STUDY; MALE; OIL INDUSTRY; PRIORITY JOURNAL; VACCINATION; VIRUS CARRIER;

ADULT; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; PERSONNEL, HOSPITAL; SEX FACTORS; VACCINATION;

EID: 38049123438     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f1cc28     Document Type: Article

References (25)

1. Alavian SM. Ministry of health in Iran is serious about controlling hepatitis B. Hep Mon 2007; 7:3-5.
2. Szmuness W, Prince AM, Grady GF, Mann MK, Levine RW, Friedman EA, et al. Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA 1974; 227:901-906.
3. Geretty RJ. Hepatitis B transmission between dental or medical workers and patients. Ann Intern Med 1981; 95:229-231.
4. Seyckova J, Helc J. Prevalence of viral hepatitis among the hospital staff in CSR between 1980 and 1982. J Hyg Epidemiol Microbiol Immunol 1984; 28:267-278.
5. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991; 11:84-92.
6. McMahon BJ, Rhoades ER, Heyward WL, Tower E, Ritter D, Lanier AP, et al. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives. Lancet 1987; 2:1134-1136.
7. Dienstag JL, Werner BG, Polk F, Snydman DR, Craven DE, Platt R, et al. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med 1984; 101:34-40.
8. Peces R, Laures AS. Persistence of immunologic memory in long-term hemodialysis patients and health care workers given hepatitis B vaccine: role of booster dose on antibody response. Nephron 2001; 89:172-176.
9. Marinho RT, Pedro M, Ramalho F, Velosa J, De Moura MC. Vaccine against hepatitis B. Eight years of experience (in Portuguese). Acta Med Port 1998; 11:971-977.
10. Panizo Delgado A, Martinez Artola V. Hepatitis B vaccination: immunogenicity of the plasmatic vaccine in hospital personnel [in Spanish]. Med Clin (Barc) 1989; 92:401-404.
11. Coursaget P, Yvonnet B, Gilks WR, Wang CC, Day NE, Chiron JP. Scheduling of revaccination against hepatitis B virus. Lancet 1991; 337:1180-1183.
12. Simo Minana J, Gaztambide Ganuza M, Fernandez Millan P, Pena Fernandez M. Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination. Vaccine 1996; 14:103-106.
13. Chadha MS, Arankalle VA. Ten year serological follow up of hepatitis B vaccine recipients. Indian J Gastroenterol 2000; 19:168-171.
14. Darvish Moghaddam S, Zahedi MJ, Yazdani R. Persistence of immune response after hepatitis B vaccination in medical students and residents. Arch Iranian Med 2004; 7:37-40.
15. Saberifiroozi M, Gholamzadeh S, Serati AR. The long-term immunity among health care workers vaccinated against hepatitis B virus in a large referral hospital in southern Iran. Arch Iranian Med 2006; 9:204-207.
16. Alavian SM. Immunization: an important strategy to control hepatitis B. Hep Mon 2006; 6:3-5.
17. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med 1997; 157:2601-2605.
18. Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, et al. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine 2004; 22: 607-610.
19. European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000; 355:561-565.
20. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iranian Med 2000; 3:192-201.
21. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142:333-341.
22. Amini S, Andalibi S, Mahmoodi M. Anti-HBs response and its protective effect in children and adults receiving hepatitis B recombinant vaccine in Tehran. Iranian J Med Sci 2002; 27:101-105.
23. Shokrgozar MA, Shokri F. HLA-associated antibody response to recombinant hepatitis B vaccine in healthy Iranian adults. Iranian J Med Sci 1999; 24:98-103.
24. Ayerbe MC, Perez Rivilla A, ICOVAHB Group. Assessment of long-term efficacy of hepatitis B vaccine. Eur J Epidemiol 2001; 17:150-156.
25. Shakhgildian IV, Khulkhlovich PA, Saving EA, Kuzin SN, Anan'ev VA, Sergeeva NA, et al. Risk of infection with hepatitis B and C viruses of medical workers, patients in the hemodialysis ward, and vaccine prophylaxis of hepatitis B infection in these populations [in Russian]. Vopr Virusol 1994; 39:226-229.